(Q51938755)

English

Optimizing randomized phase II trials assessing tumor progression.

scientific article published on 19 May 2006

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

title

Optimizing randomized phase II trials assessing tumor progression. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

main subject

phase II clinical trial

0 references

1 reference

Andrew Stone

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

Catherine Wheeler

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

Kevin Carroll

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

Alan Barge

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

language of work or name

English

0 references

publication date

19 May 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

published in

Contemporary Clinical Trials

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

volume

28

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

page(s)

146-152

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

Identifiers

DOI

10.1016/J.CCT.2006.05.003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

PubMed publication ID

16807129

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16807129

retrieved

18 April 2018

reference URL

http://europepmc.org/abstract/MED/16807129

(Q51938755)

Optimizing randomized phase II trials assessing tumor progression.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)